Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients

NCT01394640

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +17 more
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

View Trial Details

Completed

Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma

NCT00574626

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00004192

Conditions: Agranulocytosis, Blood Protein Disorders, Burkitt Lymphoma, +42 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

Ireland Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's Lymphoma

NCT00004198

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation

NCT00031642

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +28 more
Locations: Eppley Cancer Center at University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

NCT00007865

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +28 more
Locations: University of Nebraska Medical Center, Eppley Cancer Center Omaha, Nebraska, United States

View Trial Details

Completed

AIMN Multicenter Study: Staging of Lymphomas Using PET/CT

NCT06179693

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Irccs San Raffaele Milan, Italy

View Trial Details

Completed

CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies

NCT00968760

Conditions: B-cell Lymphoma, Chronic Disease, Disease Attributes, +19 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma

NCT01088750

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Universitaetsklinikum Giessen-Marburg Giessen, Germany

View Trial Details

Completed

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

NCT01421524

Conditions: Adenocarcinoma, Astrocytoma, Blood Protein Disorders, +35 more
Locations: City of Hope Cancer Center Duarte, California, United States

UCLA Neuro-Oncology Program Los Angeles, California, United States

UCSF Helen Diller Medical Center at Parnassus Heights San Francisco, California, United States

University Of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View all 39 locations

View Trial Details